Caricamento...
Recent advances in understanding idiopathic pulmonary fibrosis
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dismal prognosis of idiopathic pulmonary fibrosis (IPF) remains unchanged. The elaboration of international diagnostic criteria and disease stratification models based on clinical, physiological, radiolo...
Salvato in:
| Pubblicato in: | F1000Res |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000Research
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4890320/ https://ncbi.nlm.nih.gov/pubmed/27303645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8209.1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|